MEASUREMENT OF APOLIPOPROTEIN-B AS A SCREENING-TEST FOR IDENTIFYING CHILDREN WITH ELEVATED LEVELS OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL

被引:16
作者
DENNISON, BA
KIKUCHI, DA
SRINIVASAN, SR
WEBBER, LS
BERENSON, GS
机构
[1] LOUISIANA STATE UNIV, MED CTR, DEPT PEDIAT, NEW ORLEANS, LA 70112 USA
[2] LOUISIANA STATE UNIV, MED CTR, DEPT BIOMETRY & GENET, NEW ORLEANS, LA 70112 USA
[3] LOUISIANA STATE UNIV, MED CTR, DEPT BIOCHEM, NEW ORLEANS, LA 70112 USA
关键词
D O I
10.1016/S0022-3476(05)81073-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We compared the efficacy of two screening tests, measurement of apolipoprotein B (apo B) levels and measurement of serum total cholesterol levels, in detecting elevated low-density lipoprotein cholesterol (LDL-C) values in children. We studied 2850 children, aged 5 to 17 years, who had fasting lipid, lipoprotein, and apolipoprotein levels measured as part of the Bogalusa Heart Study. The test characteristics of apo B were superior to those of serum total cholesterol in screening children to detect elevated levels of LDL-C (≥95th percentile) and moderately elevated LDL-C levels (≥80th percentile). Unusually high or low values of high-density lipoprotein cholesterol are responsible for most of the misclassification that occurs when measurement of total cholesterol is used as a screening test for identifying children with elevated levels of LDL-C. This confounding effect of high-density lipoprotein cholesterol was eliminated when measurement of apo B levels was used as a screening test. Because the apo B test is more specific at a given sensitivity than the total cholesterol test, the apo B test can cost more and still be less expensive as a screening strategy. As the methods for determining apolipoprotein levels become standardized and readily available, the measurement of apolipoproteins could be developed into superior screening tests for the identification of patients with dyslipidemias. © 1990 Mosby-Year Book, Inc.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 29 条
[1]  
BERENSON GS, 1980, CARDIOVASCULAR RISK
[2]  
BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080
[3]   EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].
BRENSIKE, JF ;
LEVY, RI ;
KELSEY, SF ;
PASSAMANI, ER ;
RICHARDSON, JM ;
LOH, IK ;
STONE, NJ ;
ALDRICH, RF ;
BATTAGLINI, JW ;
MORIARTY, DJ ;
FISHER, MR ;
FRIEDMAN, L ;
FRIEDEWALD, W ;
DETRE, KM ;
EPSTEIN, SE .
CIRCULATION, 1984, 69 (02) :313-324
[4]   RELATION OF PARENTAL HISTORY OF EARLY MYOCARDIAL-INFARCTION TO THE LEVEL OF APOPROTEIN-B IN MEN [J].
CAMBIEN, F ;
WARNET, JM ;
JACQUESON, A ;
DUCIMETIERE, P ;
RICHARD, JL ;
CLAUDE, JR .
CIRCULATION, 1987, 76 (02) :266-271
[5]  
DENNISON BA, 1990, PEDIATRICS, V85, P472
[6]   PARENTAL HISTORY OF CARDIOVASCULAR-DISEASE AS AN INDICATION FOR SCREENING FOR LIPOPROTEIN ABNORMALITIES IN CHILDREN [J].
DENNISON, BA ;
KIKUCHI, DA ;
SRINIVASAN, SR ;
WEBBER, LS ;
BERENSON, GS .
JOURNAL OF PEDIATRICS, 1989, 115 (02) :186-194
[7]   RADIAL IMMUNODIFFUSION ASSAY OF APOLIPOPROTEIN-B IN BLOOD DRIED ON FILTER-PAPER - A POTENTIAL SCREENING METHOD FOR FAMILIAL TYPE-II HYPERCHOLESTEROLEMIA [J].
DUDMAN, NPB ;
BLADES, BL ;
WILCKEN, DEL ;
AITKEN, JM .
CLINICA CHIMICA ACTA, 1985, 149 (2-3) :117-127
[8]  
FLETCHER RH, 1982, CLIN EPIDEMIOLOGY, P49
[9]   THE RELATION OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B IN CHILDREN TO PARENTAL MYOCARDIAL-INFARCTION [J].
FREEDMAN, DS ;
SRINIVASAN, SR ;
SHEAR, CL ;
FRANKLIN, FA ;
WEBBER, LS ;
BERENSON, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) :721-726
[10]  
FREEDMAN DS, 1987, PEDIATRICS, V80, P789